Search Results

Filter
  • 1-10 of  37,037 results for ""Pamidronate""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Chronic non-bacterial osteomyelitis (CNO) and chronic recurrent multifocal osteomyelitis (CRMO) with a focus on pamidronate therapy.

  • Authors : Bouchalova K; Department of Pediatrics, Faculty of Medicine and Dentistry, Palacky University Olomouc and University Hospital Olomouc, Czech Republic.; Pytelova Z

Subjects: Osteomyelitis*/Osteomyelitis*/Osteomyelitis*/drug therapy ; Osteomyelitis*/Osteomyelitis*/Osteomyelitis*/diagnostic imaging ; Pamidronate*/Pamidronate*/Pamidronate*/therapeutic use Chronic recurrent multifocal osteomyelitis

  • Source: Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia [Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub] 2024 Sep; Vol. 168 (3), pp. 191-199. Publisher: Vydavatelství Univerzity Palackého Country of Publication: Czech Republic NLM ID: 101140142 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Bone alterations of pamidronate therapy in children with cerebral palsy complicating orthopedic management.

Subjects: Pamidronate*/Pamidronate*/Pamidronate*/therapeutic use ; Cerebral Palsy*/Cerebral Palsy*/Cerebral Palsy*/complications ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use

  • Source: Journal of pediatric orthopedics. Part B [J Pediatr Orthop B] 2024 Jul 01; Vol. 33 (4), pp. 407-410. Date of Electronic Publication: 2023 Oct 09.Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9300904 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report.

  • Authors : Oh YI; Department of Veterinary Internal Medicine, College of Veterinary Medicine & Institute for Veterinary Biomedical Science, Kyungpook National University, Daegu, 41566, Republic of Korea.; An JH

Subjects: Pamidronate*/Pamidronate*/Pamidronate*/therapeutic use ; Hypocalcemia*/Hypocalcemia*/Hypocalcemia*/veterinary ; Hypocalcemia*/Hypocalcemia*/Hypocalcemia*/chemically induced

  • Source: BMC veterinary research [BMC Vet Res] 2024 May 24; Vol. 20 (1), pp. 227. Date of Electronic Publication: 2024 May 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-6148

Record details

×
Academic Journal

Pamidronate Response in a Novel Biallelic CREB3L1 Gene Mutation-Associated Osteogenesis Imperfecta: A Case Report.

  • Authors : Selina A; Department of Paediatric Orthopaedic, Christian Medical College, Vellore, Tamil Nadu, India.; Centre for Stem Cell Research, Christian Medical College, Vellore, Tamil Nadu, India.

Subjects: Osteogenesis Imperfecta*/Osteogenesis Imperfecta*/Osteogenesis Imperfecta*/genetics ; Osteogenesis Imperfecta*/Osteogenesis Imperfecta*/Osteogenesis Imperfecta*/drug therapy ; Pamidronate*/Pamidronate*/Pamidronate*/therapeutic use

  • Source: JBJS case connector [JBJS Case Connect] 2024 Jul 26; Vol. 14 (3). Date of Electronic Publication: 2024 Jul 26 (Print Publication: 2024).Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 101596828 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pamidronate-induced SDRIFE confirmed by skin testing without cross reactivity to zoledronate.

  • Authors : Barthalon E; National Reference Center on Severe cutaneous Drug Reaction Unit, Groupe Hospitalier Centre, Dermatology, Clinical Immunology Hospices civils de Lyon, Inserm U851, University Claude Bernard Lyon 1, Lyon, France.; Dupire G

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/adverse effects ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Diphosphonates*/Diphosphonates*/Diphosphonates*/adverse effects

  • Source: European journal of dermatology : EJD [Eur J Dermatol] 2024 Jun 01; Vol. 34 (3), pp. 304.Publisher: John Libbey Eurotext Country of Publication: France NLM ID: 9206420 Publication Model: Print Cited Medium: Internet ISSN: 1952-4013

Record details

×
Academic Journal

A non-lethal presentation of osteogenesis imperfecta type VIII due to homozygous mutation in P3H1 gene.

  • Authors : Khadse S; Pediatrics, Lokmanya Tilak Municipal General Hospital and Lokmanya Tilak Municipal Medical College, Mumbai, Maharashtra, India.; Shankaramurthy P

Subjects: Osteogenesis Imperfecta*/Osteogenesis Imperfecta*/Osteogenesis Imperfecta*/genetics ; Osteogenesis Imperfecta*/Osteogenesis Imperfecta*/Osteogenesis Imperfecta*/drug therapy ; Homozygote*

  • Source: BMJ case reports [BMJ Case Rep] 2024 Oct 24; Vol. 17 (10). Date of Electronic Publication: 2024 Oct 24.Publisher: BMJ Pub. Group Country of Publication: England NLM ID: 101526291 Publication Model: Electronic Cited Medium: Internet ISSN: 1757-790X

Record details

×
Academic Journal

The Influence of Local Pamidronate Application on Alveolar Dimensional Preservation after Tooth Extraction-An Animal Experimental Study.

  • Authors : Kauffmann F; Department of Oral and Craniomaxillofacial Surgery, Center for Dental Medicine, University Medical Center Freiburg, 79106 Freiburg, Germany.; Höhne C

Subjects: Alveolar Bone Loss/Alveolar Bone Loss/Alveolar Bone Loss/*prevention & control ; Bone Density Conservation Agents/Bone Density Conservation Agents/Bone Density Conservation Agents/*therapeutic use ; Pamidronate/Pamidronate/Pamidronate/*therapeutic use

  • Source: International journal of molecular sciences [Int J Mol Sci] 2020 May 20; Vol. 21 (10). Date of Electronic Publication: 2020 May 20.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Pamidronate: A model compound of the pharmacology of nitrogen-containing bisphosphonates; A Leiden historical perspective.

  • Authors : Papapoulos SE; Center for Bone Quality, Leiden University Medical Center, Albinusdreef 2, 2333, ZA, Leiden, the Netherlands. Electronic address: .

Subjects: Bone Resorption* ; Diphosphonates*/Diphosphonates*/Diphosphonates*/pharmacology ; Pamidronate*/Pamidronate*/Pamidronate*/pharmacology

  • Source: Bone [Bone] 2020 May; Vol. 134, pp. 115244. Date of Electronic Publication: 2020 Jan 17.Publisher: Elsevier Science Country of Publication: United States NLM ID: 8504048 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Pretreatment with Pamidronate Decreases Bone Formation but Increases Callus Bone Volume in a Rat Closed Fracture Model.

  • Authors : Morse A; Orthopaedic Research & Biotechnology Unit, The Children's Hospital at Westmead, Locked Bag 4001, Westmead, NSW, 2145, Australia.; Discipline of Child and Adolescent Health, Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.

Subjects: Bony Callus/Bony Callus/Bony Callus/*drug effects ; Femoral Fractures/Femoral Fractures/Femoral Fractures/*pathology ; Fractures, Closed/Fractures, Closed/Fractures, Closed/*pathology

  • Source: Calcified tissue international [Calcif Tissue Int] 2020 Feb; Vol. 106 (2), pp. 172-179. Date of Electronic Publication: 2019 Oct 01.Publisher: Springer Verlag Country of Publication: United States NLM ID: 7905481 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

The Effects of Polyphenol, Tannic Acid, or Tannic Acid in Combination with Pamidronate on Human Osteoblast Cell Line Metabolism.

  • Authors : Hapidin H; Biomedicine Programme, School of Health Sciences, Health Campus, Universiti Sains Malaysia, Kubang Kerian 16150, Malaysia.; Hashim NM

Subjects: Osteoblasts/Osteoblasts/Osteoblasts/*drug effects ; Osteoblasts/Osteoblasts/Osteoblasts/*metabolism ; Pamidronate/Pamidronate/Pamidronate/*pharmacology

  • Source: Molecules (Basel, Switzerland) [Molecules] 2022 Jan 11; Vol. 27 (2). Date of Electronic Publication: 2022 Jan 11.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

Record details

×
  • 1-10 of  37,037 results for ""Pamidronate""